Rock Springs Capital Management »

Celldex Therapeutics shares owned by Rock Springs Capital Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Rock Springs Capital Management from 13F filings

Historical chart of Rock Springs Capital Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Rock Springs Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Rock Springs Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $58M 1.4M 41.97
2023-09-30 $14M 500k 27.52
2023-06-30 $14M 422k 33.93
2023-03-31 $15M 422k 35.98
2022-12-31 $19M 422k 44.57
2022-09-30 $12M 422k 28.11
2022-06-30 $9.0M 336k 26.96
2022-03-31 $3.3M 97k 34.06